What Are Plant Growth Regulators, And Are They Bad?

Plants regulate their own growth with hormones. Gibberellins drive stem elongation; auxins govern direction; cytokinins influence cell division. A plant growth regulator is a synthetic compound that interferes with one of these systems deliberately.

The commercial logic is straightforward. A shorter, sturdier plant is easier to harvest mechanically, less likely to fall over in wind or rain, and puts a greater proportion of its energy into the part being sold rather than into stem. In cereal farming this is worth a great deal of money, which is why these compounds are used at scale worldwide.

Paclobutrazol inhibits gibberellin biosynthesis. Blocking gibberellin stops stems elongating, producing compact growth and denser flowering structures. It is registered in Australia across thirty-five commercial products, approved for apples, mangoes, avocados and stone fruit, and widely used on turf and amenity trees.

Daminozide — sold historically under the trade name Alar — also suppresses growth, and is the compound behind one of the most-litigated food safety controversies of the twentieth century. Its US food-crop registrations were voluntarily cancelled in November 1989 and its tolerances revoked the following March. It remains registered in Australia for ornamental use, and one of the two products on the register is still sold as Alar.

Chlormequat chloride reduces stem elongation, producing stockier plants. It is used heavily on cereal crops in Europe, and was approved for the first US food uses only recently.

All three are legal agricultural chemicals used under label conditions on specified crops. None of them is approved for use on plants that are subsequently burned and inhaled — a distinction that turns out to matter enormously, and which the rest of this cluster examines.

Of the three, daminozide carries the clearest documented hazard, and the reason is a breakdown product rather than the parent compound.

Daminozide contains a hydrazide group — a nitrogen–nitrogen bond. Under heat or acid it can release unsymmetrical dimethylhydrazine, usually abbreviated UDMH. Regulators treat this conversion as a given: the international residue definition for daminozide is not daminozide alone but the *sum* of daminozide and UDMH, expressed as daminozide. You define a residue that way only when you expect the parent to convert.

UDMH is classified by the International Agency for Research on Cancer as Group 2B, possibly carcinogenic to humans, and by the US National Toxicology Program as reasonably anticipated to be a human carcinogen. Both classifications rest on animal evidence — oral studies in mice and hamsters showing lung, liver and kidney tumours. There is no human epidemiology.

It is worth being precise about a detail almost always reported wrongly: the US EPA's classification of *daminozide itself* as a probable human carcinogen is explicitly derivative. In the agency's own words, "since UDMH is dependent on the presence of the parent chemical, daminozide also has been classified as a Group B2 carcinogen." Daminozide's own reference dose lists its critical effect as, literally, no adverse effects at the highest dose tested.

Three claims circulate widely and do not survive contact with the primary literature.

The first is that paclobutrazol converts to nitrosamines when heated. No primary source establishes this. The claim traces to two identifiable errors: a genuine finding about *daminozide* — which forms nitrosamines when treated with nitrite in acid — transferred onto a chemically different molecule, and a misreading of safety data sheets, which list "nitrogen oxides" among generic decomposition products. Paclobutrazol's nitrogens sit in an aromatic triazole ring; it has none of the secondary-amine chemistry nitrosamine formation requires.

The second is that these compounds are classified carcinogens as a class. They are not. Paclobutrazol is EPA Group D — *not classifiable* — a rating assigned because the available cancer study used doses too low to evaluate the question, which is a data gap rather than a clean bill of health. The International Agency for Research on Cancer has never evaluated paclobutrazol or daminozide at all; only UDMH appears in its lists. Chlormequat is not classified as a carcinogen by any regulator, and its full genotoxicity battery is negative.

The third is that the danger is settled and quantified. It isn't, in either direction — which is the subject of the rest of this cluster.

Every safety threshold attached to these compounds describes swallowing them. Reference doses come from feeding studies. Maximum residue limits are built for food. That is entirely reasonable, because these are agricultural chemicals used on food crops.

It stops being reasonable the moment the treated plant material is burned and the smoke inhaled. At that point two things change: the compound may not survive combustion intact, and whatever does reach the lung bypasses the liver's first-pass metabolism entirely.

Neither question has been answered for any plant growth regulator. Not one has ever been pyrolysed on plant material with the products identified — an experiment that has been performed for a herbicide in 1979, an insecticide in 2011, and a different growth regulator on tobacco in 2012, but never for these.

That gap, and the fact that the residue limits in force were never designed to close it, is the honest core of this subject.